These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17703938)

  • 21. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A selective androgen receptor modulator for hormonal male contraception.
    Chen J; Hwang DJ; Bohl CE; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):546-53. PubMed ID: 15347734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
    Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
    J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs).
    Nagata N; Miyakawa M; Amano S; Furuya K; Yamamoto N; Inoguchi K
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1744-7. PubMed ID: 21349712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia.
    Nejishima H; Yamamoto N; Suzuki M; Furuya K; Nagata N; Yamada S
    Prostate; 2012 Oct; 72(14):1580-7. PubMed ID: 22430536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators.
    Kim J; Wu D; Hwang DJ; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2005 Oct; 315(1):230-9. PubMed ID: 15987833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Lundeen S; Marschke KB; Zhang Z
    J Med Chem; 2002 Sep; 45(20):4379-82. PubMed ID: 12238914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective androgen receptor modulators in preclinical and clinical development.
    Narayanan R; Mohler ML; Bohl CE; Miller DD; Dalton JT
    Nucl Recept Signal; 2008; 6():e010. PubMed ID: 19079612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.
    Marhefka CA; Gao W; Chung K; Kim J; He Y; Yin D; Bohl C; Dalton JT; Miller DD
    J Med Chem; 2004 Feb; 47(4):993-8. PubMed ID: 14761201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
    Omwancha J; Brown TR
    Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
    Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
    Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pharmacophore cinnoline and quinoline systems on the basis of computer calculation and pharmacological screening of their condensed systems.
    Stańczak A; Pakulska W; Pietrzak B; Lewgowd W
    Pharmazie; 2001 Jun; 56(6):501-5. PubMed ID: 11446173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs).
    Miller CP; Bhaket P; Muthukaman N; Lyttle CR; Shomali M; Gallacher K; Slocum C; Hattersley G
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7516-20. PubMed ID: 21036041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of selective androgen receptor modulators.
    Yin D; Gao W; Kearbey JD; Xu H; Chung K; He Y; Marhefka CA; Veverka KA; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1334-40. PubMed ID: 12604714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and biological evaluation of 16-substituted 4-azasteroids as tissue-selective androgen receptor modulators (SARMs).
    Mitchell HJ; Dankulich WP; Hartman GD; Prueksaritanont T; Schmidt A; Vogel RL; Bai C; McElwee-Witmer S; Zhang HZ; Chen F; Leu CT; Kimmel DB; Ray WJ; Nantermet P; Gentile MA; Duggan ME; Meissner RS
    J Med Chem; 2009 Aug; 52(15):4578-81. PubMed ID: 19606870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.
    Marhefka CA; Moore BM; Bishop TC; Kirkovsky L; Mukherjee A; Dalton JT; Miller DD
    J Med Chem; 2001 May; 44(11):1729-40. PubMed ID: 11356108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f.
    Morimoto M; Amano Y; Oka M; Harada A; Fujita H; Hikichi Y; Tozawa R; Yamaoka M; Hara T
    PLoS One; 2017; 12(12):e0189480. PubMed ID: 29216311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-specific activation of the human skeletal alpha-actin by androgens.
    Hong MH; Sun H; Jin CH; Chapman M; Hu J; Chang W; Burnett K; Rosen J; Negro-Vilar A; Miner JN
    Endocrinology; 2008 Mar; 149(3):1103-12. PubMed ID: 18063690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.